Open AccessOlmesartan-associated severe gastritis and enteropathy
Author(s) -
Lavanya Shenbagaraj,
G. L. Swift
Publication year - 2018
Publication title -
bmj case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.231
H-Index - 26
ISSN - 1757-790X
DOI - 10.1136/bcr-2018-226133
Subject(s) - olmesartan , enteropathy , medicine , gastritis , gastroenterology , stomach , angiotensin ii receptor antagonist , duodenum , angiotensin receptor , angiotensin ii , receptor , disease , blood pressure
Olmesartan is an angiotensin II receptor antagonist, used in the treatment of hypertension. We report a case of olmesartan-associated severe gastritis with enteropathy in a 74-year-old woman who presented with mainly upper gastrointestinal symptoms. There was significant endoscopic improvement in the mucosal inflammation on stopping the drug. Subsequent gastroscopy showed mucosal healing and normal gastric and duodenal mucosa. To our knowledge, this is the first case report of olmesartan-associated gastritis and enteropathy predominantly involving and affecting the whole of stomach with limited small bowel involvement.